JP2019516775A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516775A5
JP2019516775A5 JP2018562173A JP2018562173A JP2019516775A5 JP 2019516775 A5 JP2019516775 A5 JP 2019516775A5 JP 2018562173 A JP2018562173 A JP 2018562173A JP 2018562173 A JP2018562173 A JP 2018562173A JP 2019516775 A5 JP2019516775 A5 JP 2019516775A5
Authority
JP
Japan
Prior art keywords
billion cfu
lactobacillus
pharmaceutical composition
composition according
bifidobacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2018562173A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019516775A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/033976 external-priority patent/WO2017204788A1/en
Publication of JP2019516775A publication Critical patent/JP2019516775A/ja
Publication of JP2019516775A5 publication Critical patent/JP2019516775A5/ja
Ceased legal-status Critical Current

Links

JP2018562173A 2016-05-24 2016-05-24 プロバイオティクス及び消化酵素の組成物並びにその調製方法及び使用 Ceased JP2019516775A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/033976 WO2017204788A1 (en) 2016-05-24 2016-05-24 Composition of probiotics and digestive enzymes and method of preparing and using the same

Publications (2)

Publication Number Publication Date
JP2019516775A JP2019516775A (ja) 2019-06-20
JP2019516775A5 true JP2019516775A5 (https=) 2019-07-25

Family

ID=60411761

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018562173A Ceased JP2019516775A (ja) 2016-05-24 2016-05-24 プロバイオティクス及び消化酵素の組成物並びにその調製方法及び使用

Country Status (12)

Country Link
US (1) US20200323929A1 (https=)
EP (1) EP3463404A4 (https=)
JP (1) JP2019516775A (https=)
KR (1) KR102380198B1 (https=)
CN (1) CN109451727A (https=)
AU (1) AU2016408376B2 (https=)
BR (1) BR112018074355A2 (https=)
CA (1) CA3025512A1 (https=)
IL (1) IL263238A (https=)
MX (1) MX2018014500A (https=)
RU (1) RU2018144897A (https=)
WO (1) WO2017204788A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3055915A1 (en) * 2017-03-10 2018-09-13 Biohm Health Llc Compositions and methods for disrupting biofilms of pathogenic bacteria or fungi
WO2019169179A1 (en) * 2018-02-28 2019-09-06 Shafer Kim Augmenting efficacy of cancer therapies using probiotic based compositions
US20210030818A1 (en) * 2018-03-09 2021-02-04 Biohm Health Llc Compositions for use in balancing microbiome
CN109528776A (zh) * 2018-06-08 2019-03-29 广东益可维健康科技有限公司 一种预防治疗口腔疾病的复合益生菌含片及其制备方法
CN109566935A (zh) * 2018-12-06 2019-04-05 张秋环 综合益生菌复合粉固体饮料的制备方法
TWI740101B (zh) * 2019-02-12 2021-09-21 大江生醫股份有限公司 降膽固醇之益生菌株的用途
KR102119133B1 (ko) 2019-05-02 2020-06-26 선정완 유산균 분말 및 노니 분말을 포함하는 프로바이오틱스 조성물
KR102124474B1 (ko) * 2019-08-30 2020-06-19 주식회사 에이치이엠 Pmas방법을 이용한 개인 맞춤형 장내 환경 개선 물질 스크리닝 방법
ES3013459T3 (en) 2019-08-30 2025-04-14 Hem Pharma Inc Method for screening personalized gut environment-improving substance using pmas process
KR102335928B1 (ko) * 2019-10-02 2021-12-08 한국생명공학연구원 비만의 예방, 치료 또는 개선용 조성물
CN111213885A (zh) * 2020-01-20 2020-06-02 齐海心 一种具有调节血脂功效的益生菌组合物及其制备方法与应用
TW202203950A (zh) * 2020-03-30 2022-02-01 香港商香港微生物菌群創新中心有限公司 微生物在調節體重和膽固醇水準中的用途
CN111558033A (zh) * 2020-05-14 2020-08-21 广州中昱医学生物科技有限公司 一种口腔清洁组合物及其应用
CN112021575A (zh) * 2020-09-17 2020-12-04 泉州亚林新材料科技有限公司 一种益生菌组合物及其制备方法
KR20230156825A (ko) * 2021-01-19 2023-11-14 에이티알 쓰라이브 엘엘씨 성인 영양을 위한 우유와 효소의 조성물
CN113244408A (zh) * 2021-06-02 2021-08-13 河北源民生物科技有限公司 一种适用于肠胃的益生菌组合物
JP2023159522A (ja) * 2022-04-20 2023-11-01 国立大学法人 和歌山大学 短鎖脂肪酸産生促進用組成物
CN115025132B (zh) * 2022-06-09 2024-01-30 康永波 一种合生元组合物及其制备方法和应用
CN116042486B (zh) * 2023-02-22 2024-11-08 高邮市人民医院 一种用于治疗动脉粥样硬化的复合菌制剂
WO2025076281A1 (en) * 2023-10-06 2025-04-10 Biohm Health Inc. Microbiome modulating formula for menopausal-aged women

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7432097B2 (en) * 1997-08-13 2008-10-07 Verenium Corporation Phytases, nucleic acids encoding them and methods of making and using them
US6436451B1 (en) * 1999-03-26 2002-08-20 Eggland's Best, Inc. Method of reducing cholesterol in chicken eggs
US6368617B1 (en) * 2001-05-15 2002-04-09 Reliv' International, Inc. Dietary supplement
US20040071685A1 (en) * 2002-10-09 2004-04-15 Devin Houston Compositions and methods for increasing the bioavailability of plant polyphenols
GB2465814B (en) * 2008-06-19 2011-10-26 Tarig Sayed Mustafa Arbab Method,composition and device for the treatment of enzymes and saccharides disorders
US8257694B2 (en) * 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
BR112012024674B1 (pt) * 2010-04-26 2019-07-02 Novozymes A/S Grânulo, e, composição de detergente granular
US9301983B2 (en) * 2014-03-07 2016-04-05 Genmont Biotech Inc. Composition and method of Lactobacillus reuteri GMNL-89 in treating type 2 diabetes
WO2015172191A1 (en) * 2014-05-12 2015-11-19 Medlab Ip Pty Ltd Probiotic compositions and uses thereof for treatment of obesity-related disorders
AU2015100952A4 (en) * 2014-07-17 2015-08-20 Pharm-A-Care Laboratories Pty Ltd Probiotic- and enzyme-containing compositions and uses thereof

Similar Documents

Publication Publication Date Title
JP2019516775A5 (https=)
RU2018144897A (ru) Композиции пробиотиков и пищеварительных ферментов и способы их получения и применения
KR101902035B1 (ko) 산성 분해로부터 미생물 세포의 보호
US11617772B2 (en) Nutritional supplements and therapeutic compositions comprising probiotics
JP2020510084A (ja) 哺乳動物において健康な微生物フローラを促進するための組成物および方法
RS64782B1 (sr) Upotreba mikrobnih zajednica za zdravlje ljudi i životinja
CN104434999A (zh) 一种治疗妇女炎症的益生菌栓塞和胶囊的制备方法
JP2017512500A5 (https=)
RU2014107770A (ru) Композиция, содержащая n-ацетилцистеин и/или микроинкапсулированный защищенный от действия желудочного сока лизоцим в сочетании с пробиотическими бактериями, способная восстанавливать собственный барьерный эффект желудка, который утрачивается во время фармалогического лечения желудочной гиперацидности
AU2012210575A1 (en) Protection of microbial cells from acidic degradation
US9439953B2 (en) Compositions comprising alkaline sphingomyelinases for use as a dietetic preparation, food supplement or pharmaceutical product and methods for using them
JP2024523383A (ja) 神経障害を有する対象における胃腸症状を緩和するためのプロバイオティック組成物
AU778946B2 (en) Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
JP2003501399A5 (https=)
CN101357143A (zh) 益生菌粉组成物及其制品
Bermúdez-Humarán et al. Use of traditional and genetically modified probiotics in human health: what does the future hold?
CN101076346A (zh) 乳酸菌及其在预防腹泻中的应用
JPWO2020236979A5 (https=)
De Carvlho et al. Evaluation of the role of environmental factors in the human gastrointestinal tract on the behaviour of probiotic cultures of Lactobacillus casei Shirota and Lactobacillus casei LC01 by the use of a semi-dynamic in vitro model
JP2004250338A (ja) 有用生菌製剤
JP2008519018A5 (https=)
US20210401760A1 (en) Composite Coating for an Active Agent
TWM602906U (zh) 黃金克菲爾菌之外層微粒包埋結構
JP2025519403A (ja) 腸の健康を改善するのに使用するためのビタミンb2
Koilybayeva et al. ASFENDIYAROV KAZAKH NATIONAL MEDICAL UNIVERSITY, ALMATY, KAZAKHSTAN PROBIOTICS: ROLE IN THE CONTEMPORARY MEDICINE AND PHARMACY